GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Scaled Net Operating Assets

TuHURA Biosciences (TuHURA Biosciences) Scaled Net Operating Assets : -0.28 (As of Dec. 2022)


View and export this data going back to 2050. Start your Free Trial

What is TuHURA Biosciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TuHURA Biosciences's operating assets for the quarter that ended in Dec. 2022 was $0.94 Mil. TuHURA Biosciences's operating liabilities for the quarter that ended in Dec. 2022 was $2.76 Mil. TuHURA Biosciences's Total Assets for the quarter that ended in Dec. 2021 was $6.40 Mil. Therefore, TuHURA Biosciences's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2022 was -0.28.


TuHURA Biosciences Scaled Net Operating Assets Historical Data

The historical data trend for TuHURA Biosciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Scaled Net Operating Assets Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22
Scaled Net Operating Assets
-0.88 -0.28

TuHURA Biosciences Semi-Annual Data
Dec21 Dec22
Scaled Net Operating Assets -0.88 -0.28

Competitive Comparison of TuHURA Biosciences's Scaled Net Operating Assets

For the Biotechnology subindustry, TuHURA Biosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TuHURA Biosciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's Scaled Net Operating Assets falls into.



TuHURA Biosciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TuHURA Biosciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2022 )
=(Operating Assets (A: Dec. 2022 )-Operating Liabilities (A: Dec. 2022 ))/Total Assets (A: Dec. 2021 )
=(0.944-2.755)/6.402
=-0.28

where

Operating Assets(A: Dec. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=15.197 - 14.253
=0.944

Operating Liabilities(A: Dec. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.893 - 0.021 - 0.117
=2.755

TuHURA Biosciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2022 )
=(Operating Assets (Q: Dec. 2022 )-Operating Liabilities (Q: Dec. 2022 ))/Total Assets (Q: Dec. 2021 )
=(0.944-2.755)/6.402
=-0.28

where

Operating Assets(Q: Dec. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=15.197 - 14.253
=0.944

Operating Liabilities(Q: Dec. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.893 - 0.021 - 0.117
=2.755

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TuHURA Biosciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of TuHURA Biosciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


TuHURA Biosciences (TuHURA Biosciences) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
Website
TuHURA Biosciences Inc is a clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies. The company's lead personalized cancer vaccine candidate, IFx-Hu2.0, is designed to prime the activation of the immune system to target and attack tumor cells by making them look like bacteria. Through an intratumoral injection of a gene coding for emm55, an immunogenic bacterial protein that is then expressed on the surface of tumor cells, the immune system is activated, providing a potent, multivalent systemic response against all neoantigens in a patient's tumor.

TuHURA Biosciences (TuHURA Biosciences) Headlines

No Headlines